Procalcitonin: a new marker of inflammation in haemodialysis patients?

Background. Although procalcitonin (PCT) has been described as a new marker of infection and inflammation, it has not been extensively studied in dialysis patients. Methods. We measured plasma PCT levels in 62 patients on maintenance haemodialysis (30 M/32 F, age 61.8±17.1 years, on dialysis for 75±...

Full description

Saved in:
Bibliographic Details
Published inNephrology, dialysis, transplantation Vol. 16; no. 5; pp. 980 - 986
Main Authors Level, Claude, Chauveau, Philippe, Delmas, Yahsou, Lasseur, Catherine, Pellé, Gaëlle, Peuchant, Evelyne, Montaudon, Danièle, Combe, Christian
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.05.2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background. Although procalcitonin (PCT) has been described as a new marker of infection and inflammation, it has not been extensively studied in dialysis patients. Methods. We measured plasma PCT levels in 62 patients on maintenance haemodialysis (30 M/32 F, age 61.8±17.1 years, on dialysis for 75±93 months, 12 h/week, with a Kt/V of 1.53±0.31, high‐flux membrane being used in 25 patients and low‐flux in 37 patients, without reuse). PCT levels were compared with other markers of inflammation and nutritional status, including C‐reactive protein (CRP), fibrinogen, interleukin‐6 (IL‐6), leukocytes, urea, creatinine, albumin, prealbumin, normalized protein catabolic rate (nPCR), haemoglobin (Hb), and epoetin (Epo) doses. Patients were divided into different groups according to their infectious and vascular status. Results. PCT plasma levels before dialysis were 0.69±0.81 ng/ml. Fifty‐seven per cent of PCT values were higher than the upper normal limit of 0.5 ng/ml. CRP and PCT concentrations were high in patients with a current infection, while IL‐6 values were elevated in all patients regardless of infection status. Plasma CRP concentrations before dialysis were 21.2±31.4 mg/l, and 70% of these values were higher than the upper normal limit. CRP, PCT, IL‐6, and fibrinogen were positively correlated with each other and were all negatively correlated with albumin. Prealbumin was negatively correlated with CRP and IL‐6. In the 43 patients treated with Epo, haemoglobin was negatively correlated with IL‐6 and Epo doses, while Epo doses were positively correlated with IL‐6 but not with CRP or PCT. The 23 patients with both elevated PCT and CRP plasma levels had the lowest Hb, albumin, and prealbumin concentrations, and the highest fibrinogen concentrations and Epo doses. Conclusion. PCT in haemodialysis patients is positively correlated with currently used markers of inflammation such as CRP and fibrinogen, and negatively correlated with markers of nutritional status such as albumin. The concomitant elevations in PCT and CRP could be more sensitive in the evaluation of inflammation than each marker separately.
Bibliography:local:160980
PII:1460-2385
istex:5AB587149FD1DA1782C8D4477F548479476A5FB3
ark:/67375/HXZ-SCPSG9R3-J
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/16.5.980